S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
Log in

NYSE:LCILannett Stock Price, Forecast & News

$5.28
+0.38 (+7.76 %)
(As of 07/15/2020 01:58 PM ET)
Add
Compare
Today's Range
$5.00
Now: $5.28
$5.42
50-Day Range
$5.24
MA: $7.23
$8.35
52-Week Range
$4.89
Now: $5.28
$15.52
Volume541,843 shs
Average Volume706,185 shs
Market Capitalization$212.85 million
P/E RatioN/A
Dividend YieldN/A
Beta1.87
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Read More
Lannett logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP51601210
Phone215-333-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$655.41 million
Cash Flow$3.45 per share
Book Value$8.49 per share

Profitability

Net Income$-272,110,000.00

Miscellaneous

Employees1,020
Market Cap$212.85 million
Next Earnings Date8/25/2020 (Estimated)
OptionableOptionable

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Lannett (NYSE:LCI) Frequently Asked Questions

How has Lannett's stock been impacted by COVID-19 (Coronavirus)?

Lannett's stock was trading at $7.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LCI stock has decreased by 31.8% and is now trading at $5.2750. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Lannett?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Lannett.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Lannett.

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) posted its quarterly earnings data on Wednesday, May, 6th. The company reported $0.27 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.28 by $0.01. The company had revenue of $144.37 million for the quarter, compared to the consensus estimate of $134.55 million. Lannett had a negative net margin of 5.77% and a positive return on equity of 14.54%. The firm's revenue for the quarter was down 16.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.68 EPS. View Lannett's earnings history.

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $535-545 million, compared to the consensus revenue estimate of $541.95 million.

What price target have analysts set for LCI?

2 Wall Street analysts have issued 1-year price objectives for Lannett's stock. Their forecasts range from $14.00 to $14.00. On average, they anticipate Lannett's share price to reach $14.00 in the next year. This suggests a possible upside of 165.4% from the stock's current price. View analysts' price targets for Lannett.

Has Lannett been receiving favorable news coverage?

Press coverage about LCI stock has been trending extremely negative on Wednesday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Lannett earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the company's share price in the immediate future. View the latest news about Lannett.

Are investors shorting Lannett?

Lannett saw a decline in short interest in June. As of June 15th, there was short interest totaling 9,680,000 shares, a decline of 7.0% from the May 31st total of 10,410,000 shares. Based on an average daily trading volume, of 626,700 shares, the short-interest ratio is currently 15.4 days. Currently, 30.8% of the shares of the stock are sold short. View Lannett's Current Options Chain.

Who are some of Lannett's key competitors?

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Celgene (CELG), Akorn (AKRX), Skechers USA (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Mr. Timothy C. Crew, CEO & Director (Age 58)
  • Mr. Martin P. Galvan, VP of Fin. & CFO (Age 67)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 57)
  • Mr. John M. Abt, VP & Chief Quality Operations Officer (Age 54)
  • Mr. John Kozlowski, Chief of Staff & Strategy Officer (Age 47)

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Who are Lannett's major shareholders?

Lannett's stock is owned by a number of institutional and retail investors. Top institutional investors include Fortem Financial Group LLC (0.04%). Company insiders that own Lannett stock include Albert Paonessa III, David A Drabik, Jeffrey Farber, Patrick G Lepore and Timothy C Crew. View institutional ownership trends for Lannett.

Which major investors are buying Lannett stock?

LCI stock was bought by a variety of institutional investors in the last quarter, including Fortem Financial Group LLC. Company insiders that have bought Lannett stock in the last two years include Albert Paonessa III, Jeffrey Farber, Patrick G Lepore, and Timothy C Crew. View insider buying and selling activity for Lannett.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $5.28.

How big of a company is Lannett?

Lannett has a market capitalization of $212.85 million and generates $655.41 million in revenue each year. The company earns $-272,110,000.00 in net income (profit) each year or $2.35 on an earnings per share basis. Lannett employs 1,020 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.